Previous close | 2,292.50 |
Open | 2,296.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 2,289.00 - 2,318.00 |
52-week range | 2,238.00 - 2,966.50 |
Volume | |
Avg. volume | 2,148,437 |
Market cap | 1.076T |
Beta (5Y monthly) | 0.18 |
PE ratio (TTM) | 8.68 |
EPS (TTM) | 263.87 |
Earnings date | 09 May 2024 |
Forward dividend & yield | 80.00 (3.49%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | 2,742.70 |
Q4 2023 Cue Biopharma Inc Earnings Call
Advancements in Clinical Trials and Strong Cash Position Highlighted
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that in order to accelerate the open innovation, it has increased its investment pool from US$100 million to US$200 million to continue strategic investment in Ono Venture Investment Fund I, L.P. ("OVI FI"), which was established as a corporate venture capital fund in CA, USA in May 2020.